A ‘minimum dose’ of lipopolysaccharide required for implantation failure: assessment of its effect on the maternal reproductive organs and interleukin-1α expression in the mouse
- 1 July 2004
- journal article
- Published by Bioscientifica in Reproduction
- Vol. 128 (1) , 87-97
- https://doi.org/10.1530/rep.1.00110
Abstract
Genital tract infections caused by gram-negative bacteria induce abortion and are one of the most common complications of human pregnancy. This study was carried out to decipher the mechanism of gram-negative bacterial lipopolysaccharide (LPS)-induced pregnancy loss, using a mouse (Park strain) model. Since many of the biological effects of LPS are mediated by interleukin (IL)-1α, the role of IL-1α in LPS-induced pregnancy loss was studied. Pregnant female animals were injected intra-peritoneally (i.p.) with different doses (1 to 50 μg) of LPS fromSalmonella minnesotaRe-595, on day 0.5 of pregnancy. We found that 250 μg/kg body weight (i.e. 5 μg/female mouse) of LPS when given on day 0.5 of pregnancy was the ‘minimum dose’ (MD) required to completely inhibit the implantation of the blastocyst in the mouse. The effect of this dose on the pathophysiology of the various reproductive organs (i.e. uterus, ectoplacental cones, developing fetus, ovaries etc.) was assessed on day 14 of pregnancy. The effects of this dose on the level and pattern of expression of the proinflammatory cytokine IL-1α in the maternal uterine horns and preimplantation stage embryos were studied by RT-PCR. A single dose (100 ng/mouse) of recombinant mouse IL-1α was given i.p. to pregnant females on day 1 of pregnancy to study its effect on implantation. Our results show that treatment of the pregnant animals with LPS may alter cell proliferation and induce leukocyte infiltration, degeneration of luminal glandular epithelium, and hyperplasia in the various reproductive organs, and may also alter both embryonic and uterine IL-1α expression. IL-1α administration also caused implantation failure similar to that of LPS. The observations suggest that the determined MD of LPS may alter the expression of developmentally important proinflammatory cytokines such as IL-1α, which could, in turn, inhibit the normal processes of blastocyst implantation. Therefore, it is proposed that the LPS-induced histopathological alterations in the various reproductive organs of pregnant animals could be mediated by IL-1α and this may be one of the causes of failure of blastocyst implantation in the mouse.Keywords
This publication has 36 references indexed in Scilit:
- IntroductionSeminars in Cell & Developmental Biology, 2000
- Embryonic Regulation of Integrins 3, 4, and 1 in Human Endometrial Epithelial Cells in VitroJournal of Clinical Endocrinology & Metabolism, 1997
- Review: Cytokine Involvement in Ovarian ProcessesAmerican Journal of Reproductive Immunology, 1997
- Matrix Metalloproteinase Expression During Mouse Peri‐implantation DevelopmentAmerican Journal of Reproductive Immunology, 1996
- Lipopolysaccharide Inhibits in Vitro Luteinizing Hormone-Stimulated Rat Ovarian Granulosa Cell Estradiol but Not Progesterone Secretion1Biology of Reproduction, 1996
- Immunological Prevention of Spontaneous Early Embryo Resorption Is Mediated by Non‐Specific ImmunosimulationAmerican Journal of Reproductive Immunology, 1996
- Interleukin-1α Regulates Prostaglandin Production and Cyclooxygenase Activity in Sensitized Rat Endometrial Stromal Cells in Vitro1Biology of Reproduction, 1995
- Control of uterine stromal mitosis in relation to uterine sensitivity and decidualization in miceReproduction, 1995
- Regulated expression of prostaglandin endoperoxide synthase-2 by uterine stromaEndocrinology, 1994
- A Murine Model of Preterm Labor: Inflammatory Mediators Regulate the Production of Prostaglandin E2 and Interleukin-6 by Murine DeciduaBiology of Reproduction, 1993